About Myoscience
Myoscience is a company based in Redwood City (United States) founded in 2005 was acquired by Pacira in March 2019.. Myoscience has raised $147.68 million across 9 funding rounds from investors including Pacira, Accuitive Medical Ventures and De Novo Ventures. The company has 687 employees as of December 31, 2021. Myoscience operates in a competitive market with competitors including Saluda Medical, Nalu Medical, Biowave, Neuros Medical and Alpha-Stim, among others.
- Headquarter Redwood City, United States
- Employees 687 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Myoscience
Myoscience has successfully raised a total of $147.68M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $5 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series F — $5.0M
-
First Round
First Round
(14 Jul 2008)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Series F - Myoscience | Valuation |
investors |
|
| Mar, 2018 | Amount | Series F - Myoscience | Valuation |
investors |
|
| Oct, 2017 | Amount | Series F - Myoscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Myoscience
Myoscience has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pacira, Accuitive Medical Ventures and De Novo Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Comprehensive strategic expertise in healthcare is provided by MEDICIS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Myoscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Myoscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Myoscience Comparisons
Competitors of Myoscience
Myoscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Saluda Medical, Nalu Medical, Biowave, Neuros Medical and Alpha-Stim, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
|
|
| domain | founded_year | HQ Location |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices are developed for pain therapy management.
|
|
| domain | founded_year | HQ Location |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| domain | founded_year | HQ Location |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Myoscience
Frequently Asked Questions about Myoscience
When was Myoscience founded?
Myoscience was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Myoscience located?
Myoscience is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Myoscience a funded company?
Myoscience is a funded company, having raised a total of $147.68M across 9 funding rounds to date. The company's 1st funding round was a Series F of $14M, raised on Jul 14, 2008.
How many employees does Myoscience have?
As of Dec 31, 2021, the latest employee count at Myoscience is 687.
What does Myoscience do?
MyoScience engages in development and commercialization of technology driven dermatological products. Company has a Focused Cold Therapy patented technology delivered by the iovera system. The iovera system is FDA cleared in the United States for use in pain management. In Europe and Canada it is approved for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. Recently, iovera has reached maximum enrollment for two knee pain studies which is a non-systemic, non-narcotic solution to blocking pain for extended period of time.
Who are the top competitors of Myoscience?
Myoscience's top competitors include Saluda Medical, Nalu Medical and Neuros Medical.
Who are Myoscience's investors?
Myoscience has 7 investors. Key investors include Pacira, Accuitive Medical Ventures, De Novo Ventures, MEDICIS, and Saratoga Ventures.